Enterprise Imaging Viewer Receives Clearance for Additional Apps
|
By MedImaging International staff writers Posted on 15 Aug 2017 |

Image: Advanced clinical applications in use on the XERO universal viewer (Photo courtesy of Agfa Healthcare).
A major medical hardware and software provider has received US FDA 510(k) clearance for additional functionalities on its enterprise imaging zero-footprint viewer.
The viewer merges patient images and data from different departments and various sources in a hospital. Clinicians inside and outside a hospital, who satisfy the security policies and have the appropriate access rights, can now use the viewer to access the Digital Imaging and Communications in Medicine (DICOM) and non-DICOM imaging data in a single consolidated view.
The US FDA approval includes Xtend 3D processing and advanced clinical applications functionality on the Agfa Healthcare (Mortsel, Belgium) XERO Viewer. The functionality is now cleared for diagnostic viewing on desktop devices.
The approved advanced clinical applications on the browser-agnostic XERO Viewer now include Maximum Intensity Projection (MIP), MultiPlanar Reconstruction (MPR), mammography, orthopedics, nuclear medicine, and 3D visualization. In addition, iPad mobile diagnostic review and analysis now includes reports and ECG images.
The viewer can display images from either the Agfa HealthCare Enterprise Imaging IT platform, third-party Vendor Neutral Archives (VNA), or Picture Archiving and Communication Systems (PACS) in a single screen.
President of Imaging IT Solutions, Agfa HealthCare, James Jay, said, "We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion. XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions. The FDA 510(k) clearance for XERO Xtend supports our continued march forward."
The viewer merges patient images and data from different departments and various sources in a hospital. Clinicians inside and outside a hospital, who satisfy the security policies and have the appropriate access rights, can now use the viewer to access the Digital Imaging and Communications in Medicine (DICOM) and non-DICOM imaging data in a single consolidated view.
The US FDA approval includes Xtend 3D processing and advanced clinical applications functionality on the Agfa Healthcare (Mortsel, Belgium) XERO Viewer. The functionality is now cleared for diagnostic viewing on desktop devices.
The approved advanced clinical applications on the browser-agnostic XERO Viewer now include Maximum Intensity Projection (MIP), MultiPlanar Reconstruction (MPR), mammography, orthopedics, nuclear medicine, and 3D visualization. In addition, iPad mobile diagnostic review and analysis now includes reports and ECG images.
The viewer can display images from either the Agfa HealthCare Enterprise Imaging IT platform, third-party Vendor Neutral Archives (VNA), or Picture Archiving and Communication Systems (PACS) in a single screen.
President of Imaging IT Solutions, Agfa HealthCare, James Jay, said, "We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion. XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions. The FDA 510(k) clearance for XERO Xtend supports our continued march forward."
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read more
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read moreMRI
view channel
New Material Boosts MRI Image Quality
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, yet certain deep or anatomically complex tissues, including delicate structures of the eye and orbit, remain difficult to visualize clearly.... Read more
AI Model Reads and Diagnoses Brain MRI in Seconds
Brain MRI scans are critical for diagnosing strokes, hemorrhages, and other neurological disorders, but interpreting them can take hours or even days due to growing demand and limited specialist availability.... Read moreMRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
Heart failure patients often require right heart catheterization to assess how severely their heart is struggling to pump blood, a procedure that involves inserting a tube into the heart to measure blood... Read more
MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
Recovery after traumatic brain injury (TBI) varies widely, with some patients regaining full function while others are left with lasting disabilities. Prognosis is especially difficult to assess in patients... Read moreUltrasound
view channel
Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
Rapid and accurate imaging is essential for diagnosing life-threatening conditions such as myocardial infarction, heart failure, and pulmonary embolism. However, conventional ultrasound imaging of the... Read more
Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
Ultrasound imaging depends on a conductive gel to eliminate air between the probe and the skin so sound waves can pass clearly into the body. While the imaging technology is fast, safe, and noninvasive,... Read moreNuclear Medicine
view channel
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
Targeted cancer therapies can be highly effective, but only when a patient’s tumor expresses the specific protein the treatment is designed to attack. Determining this usually requires biopsies or advanced... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







